Nippon Shinyaku Co., Ltd. (4516.T)
JPY 3570.0
(-1.44%)
JPY 3570.0
(-1.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 31.38 Billion JPY | 4.45% |
| 2022 | 30.04 Billion JPY | -8.8% |
| 2021 | 32.94 Billion JPY | 26.07% |
| 2020 | 26.13 Billion JPY | 20.61% |
| 2019 | 21.66 Billion JPY | 4.96% |
| 2018 | 20.64 Billion JPY | 20.87% |
| 2017 | 17.07 Billion JPY | 11.77% |
| 2016 | 15.28 Billion JPY | 78.73% |
| 2015 | 8.54 Billion JPY | -0.15% |
| 2014 | 8.56 Billion JPY | 6.52% |
| 2013 | 8.03 Billion JPY | 16.48% |
| 2012 | 6.9 Billion JPY | -48.81% |
| 2011 | 13.48 Billion JPY | 6.54% |
| 2010 | 12.65 Billion JPY | -8.75% |
| 2009 | 13.86 Billion JPY | -7.87% |
| 2008 | 15.05 Billion JPY | 12.76% |
| 2007 | 13.34 Billion JPY | 11.09% |
| 2006 | 12.01 Billion JPY | 29.73% |
| 2005 | 9.26 Billion JPY | -18.19% |
| 2004 | 11.32 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 9.77 Billion JPY | 289.17% |
| 2023 Q2 | 9.71 Billion JPY | -12.98% |
| 2023 Q1 | 11.16 Billion JPY | 441.37% |
| 2023 FY | 31.38 Billion JPY | 4.45% |
| 2023 Q4 | 2.51 Billion JPY | -75.73% |
| 2023 Q3 | 10.35 Billion JPY | 6.55% |
| 2022 Q3 | 8.82 Billion JPY | -0.66% |
| 2022 Q2 | 8.88 Billion JPY | -13.54% |
| 2022 Q1 | 10.27 Billion JPY | 183.32% |
| 2022 FY | 30.04 Billion JPY | -8.8% |
| 2022 Q4 | 2.06 Billion JPY | -76.64% |
| 2021 FY | 32.94 Billion JPY | 26.07% |
| 2021 Q3 | 7.81 Billion JPY | 48.92% |
| 2021 Q2 | 5.24 Billion JPY | -68.09% |
| 2021 Q1 | 16.44 Billion JPY | 184.96% |
| 2021 Q4 | 3.62 Billion JPY | -53.6% |
| 2020 FY | 26.13 Billion JPY | 20.61% |
| 2020 Q1 | 7.52 Billion JPY | 21.28% |
| 2020 Q3 | 9.22 Billion JPY | 154.89% |
| 2020 Q4 | 5.77 Billion JPY | -37.41% |
| 2020 Q2 | 3.61 Billion JPY | -51.9% |
| 2019 Q2 | 4.57 Billion JPY | -29.15% |
| 2019 Q4 | 6.2 Billion JPY | 39.65% |
| 2019 FY | 21.66 Billion JPY | 4.96% |
| 2019 Q3 | 4.44 Billion JPY | -2.87% |
| 2019 Q1 | 6.45 Billion JPY | 53.31% |
| 2018 Q4 | 4.2 Billion JPY | -52.53% |
| 2018 FY | 20.64 Billion JPY | 20.87% |
| 2018 Q1 | 4.84 Billion JPY | 178.99% |
| 2018 Q2 | 2.72 Billion JPY | -43.81% |
| 2018 Q3 | 8.86 Billion JPY | 225.6% |
| 2017 Q2 | 4.25 Billion JPY | -15.12% |
| 2017 Q1 | 5.01 Billion JPY | 326.17% |
| 2017 FY | 17.07 Billion JPY | 11.77% |
| 2017 Q4 | 1.73 Billion JPY | -71.41% |
| 2017 Q3 | 6.07 Billion JPY | 42.83% |
| 2016 FY | 15.28 Billion JPY | 78.73% |
| 2016 Q1 | 4.42 Billion JPY | 169.43% |
| 2016 Q4 | -2.21 Billion JPY | -120.14% |
| 2016 Q3 | 11 Billion JPY | 432.11% |
| 2016 Q2 | 2.06 Billion JPY | -53.25% |
| 2015 FY | 8.54 Billion JPY | -0.15% |
| 2015 Q4 | 1.64 Billion JPY | -65.77% |
| 2015 Q3 | 4.79 Billion JPY | 225.44% |
| 2015 Q2 | 1.47 Billion JPY | 131.76% |
| 2015 Q1 | 636 Million JPY | -75.2% |
| 2014 FY | 8.56 Billion JPY | 6.52% |
| 2014 Q1 | 814 Million JPY | -68.85% |
| 2014 Q2 | 1.21 Billion JPY | 49.75% |
| 2014 Q3 | 3.96 Billion JPY | 225.18% |
| 2014 Q4 | 2.56 Billion JPY | -35.29% |
| 2013 Q3 | 2.31 Billion JPY | 36.01% |
| 2013 FY | 8.03 Billion JPY | 16.48% |
| 2013 Q1 | 1.4 Billion JPY | -9.03% |
| 2013 Q2 | 1.7 Billion JPY | 21.7% |
| 2013 Q4 | 2.61 Billion JPY | 12.68% |
| 2012 Q4 | 1.54 Billion JPY | 211.68% |
| 2012 Q1 | 3.6 Billion JPY | 28.98% |
| 2012 Q3 | -1.37 Billion JPY | -143.92% |
| 2012 Q2 | 3.14 Billion JPY | -12.9% |
| 2012 FY | 6.9 Billion JPY | -48.81% |
| 2011 Q2 | 3.06 Billion JPY | -13.09% |
| 2011 Q3 | 4.08 Billion JPY | 33.32% |
| 2011 Q4 | 2.79 Billion JPY | -31.65% |
| 2011 FY | 13.48 Billion JPY | 6.54% |
| 2011 Q1 | 3.52 Billion JPY | 13.88% |
| 2010 Q3 | 3.64 Billion JPY | 65.55% |
| 2010 Q2 | 2.2 Billion JPY | -40.73% |
| 2010 Q1 | 3.71 Billion JPY | 147.3% |
| 2010 Q4 | 3.09 Billion JPY | -14.91% |
| 2010 FY | 12.65 Billion JPY | -8.75% |
| 2009 Q4 | 1.5 Billion JPY | -74.55% |
| 2009 FY | 13.86 Billion JPY | -7.87% |
| 2009 Q3 | 5.89 Billion JPY | 126.58% |
| 2009 Q2 | 2.6 Billion JPY | -32.62% |
| 2009 Q1 | 3.86 Billion JPY | 52.81% |
| 2008 Q2 | 2.4 Billion JPY | 0.0% |
| 2008 FY | 15.05 Billion JPY | 12.76% |
| 2008 Q3 | 4.23 Billion JPY | 75.67% |
| 2008 Q4 | 2.52 Billion JPY | -40.26% |
| 2007 FY | 13.34 Billion JPY | 11.09% |
| 2006 FY | 12.01 Billion JPY | 29.73% |
| 2005 FY | 9.26 Billion JPY | -18.19% |
| 2004 FY | 11.32 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -513.847% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 85.339% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 108.861% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 81.695% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 16153.317% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | -229.927% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 41.234% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -4283.52% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | -138.369% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -440.858% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -1498.065% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 6453.441% |
| Tsumura & Co. | 20.01 Billion JPY | -56.789% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -681.329% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -523.233% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | -77.845% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -713.53% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | -223.013% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | -421.969% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 1119.357% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -706.009% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 3966.852% |
| MedRx Co., Ltd | -933 Million JPY | 3463.987% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -509.202% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 2855.575% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 1424.304% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | -382.862% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | -66.187% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 4600.191% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | -62.361% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -616.197% |